Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0001
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed

Anthera Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
Current2017 2016 2015 2014 2013 2012 - 2008
Period Ending
Aug '24 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 2012 - 2008
Market Capitalization
023271853659
Upgrade
Market Cap Growth
-78.14%-16.09%-85.28%410.48%-38.84%-
Upgrade
Enterprise Value
61781292946
Upgrade
Last Close Price
0.001.655.1937.1212.6424.56
Upgrade
PE Ratio
--0.58-0.40-4.69-1.16-1.82
Upgrade
PS Ratio
--187.8158.09--
Upgrade
PB Ratio
1.37-4.162.124.67-16.034.02
Upgrade
P/FCF Ratio
-0.23-0.62-0.55-5.97-1.42-1.86
Upgrade
P/OCF Ratio
-0.23-0.62-0.56-5.99-1.42-1.86
Upgrade
EV/Sales Ratio
--54.5240.58--
Upgrade
EV/EBITDA Ratio
-0.15-0.47-0.14-3.70-1.03-1.64
Upgrade
EV/EBIT Ratio
-0.15-0.47-0.14-3.67-1.01-1.62
Upgrade
EV/FCF Ratio
-0.18-0.46-0.16-4.17-1.13-1.43
Upgrade
Debt / Equity Ratio
-----1.21
Upgrade
Debt / FCF Ratio
------0.56
Upgrade
Asset Turnover
--0.000.12--
Upgrade
Quick Ratio
3.060.471.965.580.463.43
Upgrade
Current Ratio
3.300.682.145.650.533.48
Upgrade
Return on Equity (ROE)
-568.85%-731.07%-211.50%-188.36%-473.78%-549.52%
Upgrade
Return on Assets (ROA)
-141.96%-167.77%-99.83%-85.35%-86.96%-55.29%
Upgrade
Return on Capital (ROIC)
-559.32%-619.42%-136.13%-117.80%-117.13%-71.11%
Upgrade
Earnings Yield
-95231721.61%-117.60%-203.88%-19.04%-81.68%-52.07%
Upgrade
FCF Yield
-122050618.46%-161.47%-182.44%-16.75%-70.63%-53.87%
Upgrade
Buyback Yield / Dilution
-152.23%-99.05%-15.94%-63.62%-19.21%-152.82%
Upgrade
Total Shareholder Return
-152.23%-99.05%-15.94%-63.62%-19.21%-152.82%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.